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Abstract: Vinegar and wine processing of medicinal plants are two traditional 
pharmaceutical techniques which have been used for thousands of years in China. 
Tetrahydropalmatine (THP), dehydrocorydaline (DHC) and protopine are three major 
bioactive molecules in Rhizoma Corydalis. In this study, a simple and reliable HPLC 
method was developed for simultaneous analysis of THP, DHC and protopine in rat tissues 
after gastric gavage administration of Rhizoma Corydalis. The validated HPLC method 
was successfully applied to investigate the effect of wine and vinegar processing on the 
compounds’ distribution in rat tissues. Our results showed that processing mainly affect the 
Tmax and mean residence time (MRT) of the molecules without changing their Cmax and 
AUC0–24 h Vinegar processing significantly increased the Tmax of DHC in heart, kidney, 
cerebrum, cerebrellum, brain stem and striatum and prolonged the Tmax of protopine in 
brain. No significant changes were observed on the Tmax of THP in rat tissues after vinegar 
processing. Wine processing reduced the Tmax of protopine and DHC in liver and spleen 
and Tmax of protopine in lung, but increased the Tmax of THP in all the rat tissues examined. 
To our knowledge, this is the first report on the effects of processing on the tissue 
distribution of the bioactive molecules from Rhizoma Corydalis. 
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1. Introduction 
The dried tuber of Corydalis yanhusuo W.T. Wang (Rhizoma Corydalis) has been successfully and 
regularly used in some Asian countries to alleviate various painful symptoms including spastic, 
abdominal and menstrual for hundreds of years [1]. The major bioactive components are three alkaloid 
compounds, namely tetrahydropalmatine (THP), dehydrocorydaline (DHC) and protopine [2,3]  
(Figure 1). Regulation of D2 dopamine receptors in central nervous system by THP and its analogues is 
the main analgesic mechanism [4]. Recently, it was found that Rhizoma Corydalis has anti-inflammatory 
and anti-tumor activities by suppressing IL-8 secretion, inhibiting aromatase activity or reducing 
cytochrome c release [5–7]. Rhizoma Corydalis can also promote blood circulation and is being used 
for the treatment of coronary heart diseases such as myocardial ischemia, infarction and stunning [8]. 
The anti-ischemia effect of Rhizoma Corydalis is associated with the direct protective function of DHC 
on cardiomyocytes and the inhibition of myocardial apoptosis [9,10]. The alkaloid protopine in 
Rhizoma Corydalis is known to have vasodilator effect [11]. 
Figure 1. Chemical structures of dehyrocorydaline (DHC), protopine and 
tetrahydropalmatine (THP). 
 
Previous reports have described the HPLC methods for simultaneous determination of THP and 
protopine in Rhizoma Corydalis and rat plasma after administration of Rhizoma Corydalis [12,13]. A 
HPLC-MS/MS method was also developed for quantitative determination of ten alkaloids in methanol 
and ethyl acetate extract of Rhizoma Corydalis [2]. However, there is no report on the simultaneous 
determination of the main bioactive compounds in rat tissues after administration of the ethanol extract 
of Rhizoma Corydalis. 
Medicinal plants sometimes require specific processing steps such as drying, water processing 
(steaming and roasting) and fire processing (stir-frying with wine, vinegar, salt or honey) to enhance 
the efficacy or reduce the toxicity of their components [14]. The processing of Rhizoma Corydalis 
using wine and vinegar was first documented in Lei's Treatise on Processing of Drugs (Leigong Pao 
Zhi Lun in Chinese) in the Tang Dynasty of China (618–907 AD). Nowadays, the procedures for 
processing Rhizoma Corydalis using vinegar and wine have been standardized according to 
pharmacists’ experiences and are listed in Pharmacopoeia of Chinese Medicine and the National 
Guideline of Traditional Chinese Medicinal Plants Processing, respectively [15].  
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The mechanisms of wine and vinegar processing have not yet been fully elucidated chemically and 
pharmacologically [16]. Comparison of analgesic and anti-inflammatory effects of wine and vinegar 
processed products of Rhizoma Corydalis showed that vinegar processed products are better than wine 
processed products [17]. Our previous results showed that the content of THP, DHC and protopine in 
ethanol extract of both wine and vinegar processed Rhizoma Corydalis was higher than that in 
unprocessed control [18]. In addition, vinegar and wine might form a chelate complex with the 
bioactive compounds in the medicinal plants and therefore change the pharmacokinetic action of the 
compounds. However, there is little information on the changes of the distribution of the bioactive 
compounds in rat tissues after the processing of the medicinal plants. The objective of this study was to 
develop a simple and accurate HPLC method for simultaneous determination of THP, DHC and 
protopine in rat tissues and investigate the effect of wine and vinegar processing of Rhizoma Corydalis 
on the distribution of THP, DHC and protopine in rat tissues. 
2. Results and Discussion  
2.1. Results 
2.1.1. Method Validation 
An analytical method for the simultaneous determination of THP, DHC and protopine in rat tissues 
by HPLC-UV was developed and validated. Figure 2 shows the representative chromatographs of a 
liver sample. The retention time was about 5.1 min for protopine, 6.1 min for THP, 7.4 min for internal 
standard nuciferine and 10.2 min for DHC. No interfering peaks were observed in drug-free tissue at 
the retention time of the analytes. 
Figure 2. Representative chromatographs of (a) a blank liver sample; (b) a liver sample 
spiked with analytes (THP (0.306 µg/mL), DHC (0.294 µg/mL), protopine (0.320 µg/mL) 
and nuciferine (1.0 µg/mL); (c) A liver sample after administration of vinegar processed 
Rhizoma Corydalis. 1-protopine; 2-THP; 3-nuciferine; 4-DHC. 
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The regression equations, correlation coefficients, linear ranges are listed in Table 1. The correlation 
coefficient (r2) for each calibration curve was over 0.99, which indicated that there was excellent 
correlation between the ratio of peak area and concentration for each compound within the linear 
range. The intra- and inter-day precision values (R.S.D.%) of THP, DHC and protopine in different 
tissue samples were all less than 5.83%. The relative extraction recoveries of THP and DHC ranged 
from 94.77%~105.82% and from 93.54%~104.76%. The relative recovery of protopine was from 
92.19% to 103.91%. This indicated that the method is reproducible and reliable for quantitative 
analysis of THP, DHC and protopine in rat tissue samples simultaneously and the extraction recovery 
was consistent and reproducible. 
Table 1. Calibration curve of THP, DHC and protopine in rat tissues. Y: Peak area ratios 
of analytes to internal standard; X: Concentration of analytes in rat tissues. 
Tissues Compounds Regression equation 
Correlation 
coefficient (r2) 
Linear range 
(µg/mL) 
Heart THP Y = 2.1542X + 0.0544 0.9997 0.0306~0.612 
DHC Y = 10.686X + 0.0350 0.9997 0.0294~0.588 
Protopine Y = 2.2532X + 0.0191 0.9996 0.0320~0.640 
Liver THP Y = 2.7012X + 0.0026 0.9983 0.0306~3.06 
DHC Y = 13.784X − 0.1516 0.9990 0.0294~2.94 
Protopine Y = 2.9222X + 0.0080 0.9992 0.0320~3.20 
Spleen THP Y = 2.6201X + 0.0310 0.9987 0.0306~3.06 
DHC Y = 12.847X + 0.0475 0.9984 0.0294~2.94 
Protopine Y = 2.7289X + 0.0966 0.9990 0.0320~3.20 
Lung THP Y = 2.7128X + 0.0130 0.9980 0.0306~3.06 
DHC Y = 12.801X + 0.0007 0.9994 0.0294~2.94 
Protopine Y = 2.8704X − 0.0077 0.9984 0.0320~3.20 
Kidney THP Y = 2.5418X + 0.0957 0.9981 0.0306~3.06 
DHC Y = 12.299X + 0.2340 0.9980 0.0294~2.94 
Protopine Y = 2.6138X + 0.0709 0.9989 0.0320~3.20 
Brain THP Y = 2.5324X + 0.0217 0.9999 0.0306~0.306 
DHC Y = 12.657X − 0.0744 0.9998 0.0294~0.294 
Protopine Y = 2.5671X + 0.0143 0.9997 0.0320~0.320 
2.1.2. Effect of Vinegar and Wine Processing on the Tissue Distribution of THP 
THP first incorporated into the liver and then transported to other tissues (spleen, lung, heart, kidney 
and brain; Figure 3). The absorption, distribution and elimination of THP were rapid since THP was 
detected in all the tissues examined within 5 min after administration and was rarely found after 8 h. 
The concentration of THP reached maxima in heart, liver, spleen, lung, cerebrum, diencephalons and 
brain stem at 15 min after administration of unprocessed and vinegar-processed Rhizoma Corydalis. 
No significant differences were observed on Tmax of THP between the vinegar processed and 
unprocessed group, but THP achieved Cmax at 30 min after administration of Rhizoma Corydalis 
processed with wine. 
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Figure 3. Time dependent changes of THP in rat tissues. (a) Heart, liver, spleen, lung and 
kidney; (b) Six parts of brain including cerebrum, cerebellum, diencephalons, brainstem, 
hippocampus, striatum. Data are mean ± SD (n = 5). 
(a) 
 
 
 
(b) 
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Figure 3. Cont. 
 
 
There were no significant changes on Cmax and AUC0–24 h of THP after vinegar and wine processing 
in all the tissues examined (Table 2). The effect of processing on the mean residence time (MRT) of 
THP varied among the tissues and between two processing methods. The MRT of THP was notably 
delayed in heart, spleen, lung, kidney, cerebrum, cerebellum, diencephalons and brainstem as a result 
of wine processing. However, the MRT of THP with wine processing was shorter in liver than the 
control groups. Vinegar processing significantly reduced the MRT of THP in spleen and kidney, while, 
it did not notably change the MRT of THP in other tissues examined.  
Table 2. Pharmacokinetic parameters of THP in rat tissues. Data are mean ± SD (n = 5). 
Data of four groups in each tissue indexed by different letters are significantly different 
according to one-way ANOVA followed by Tukey’s test (p < 0.05). 
Tissue Tmax Cmax (µg/mL) AUC0–24 h (µg·h/mL) MRT(h) 
Heart     
  Crude extract 0.25 ± 0.01b 0.59 ± 0.12a 1.44 ± 0.25a 4.61 ± 0.08b 
  Vinegar processed 0.25 ± 0.03b 0.66 ± 0.07a 1.63 ± 0.28a 4.64 ± 0.11b 
  Wine processed 0.51 ± 0.01a 0.51 ± 0.11a 1.22 ± 0.25a 5.40 ± 0.19a 
  Pure compound  0.25 ± 0.00b 0.60 ± 0.18a 1.43 ± 0.32a 4.83 ± 0.13b 
Liver     
  Crude extract 0.25 ± 0.00b 4.22 ± 0.87a 6.91 ± 2.08a 4.52 ± 0.08a 
  Vinegar processed 0.26 ± 0.02b 6.07 ± 0.64a 6.04 ± 2.87a 4.28 ± 0.07a 
  Wine processed 0.53 ± 0.04a 3.72 ± 0.78a 5.86 ± 1.22a 3.78 ± 0.13b 
  Pure compound  0.21 ± 0.01b 7.84 ± 1.74a 5.57 ± 2.60a 3.99 ± 0.08b 
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Table 2. Cont. 
Tissue Tmax Cmax (µg/mL) AUC0–24 h (µg·h/mL) MRT(h) 
Spleen     
  Crude extract 0.25 ± 0.05b 1.26 ± 0.27a 3.88 ± 0.67a 4.78 ± 0.10b 
  Vinegar processed 0.27 ± 0.01b 1.77 ± 0.19a 4.71 ± 0.85a 4.23 ± 0.07c 
  Wine processed 0.52 ± 0.04a 1.13 ± 0.24a 3.53 ± 0.71a 6.21 ± 0.24a 
  Pure compound  0.23 ± 0.00b 1.54 ± 0.45a 3.27 ± 0.74a 4.34 ± 0.09c 
Lung     
  Crude extract 0.25 ± 0.01b 1.44 ± 0.30a 5.33 ± 0.91a 5.74 ± 0.13b 
  Vinegar processed 0.28 ± 0.01b 1.68 ± 0.18a 7.02 ± 1.18a 5.27 ± 0.23b 
  Wine processed 0.51 ± 0.03a 1.04 ± 0.22a 6.56 ± 0.72a 6.23 ± 0.27a 
  Pure compound  0.26 ± 0.08b 1.53 ± 0.45a 5.93 ± 1.32a 5.34 ± 0.15b 
Kidney     
  Crude extract 0.51 ± 0.00a 1.66 ± 0.33a 4.69 ± 0.83a 5.17 ± 0.13b 
  Vinegar processed 0.53 ± 0.02a 2.12 ± 0.42a 6.78 ± 1.27a 4.50 ± 0.08c 
  Wine processed 0.58 ± 0.05a 1.45 ± 0.31a 4.32 ± 0.87a 5.65 ± 0.21a 
  Pure compound  0.33 ± 0.09b 2.05 ± 0.57a 6.27 ± 1.43a 4.37 ± 0.10c 
Cerebrum     
  Crude extract 0.25 ± 0.01b 0.22 ± 0.046a 0.75 ± 0.13a 7.82 ± 0.26b 
  Vinegar processed 0.28 ± 0.03b 0.26 ± 0.026a 0.95 ± 0.17a 7.24 ± 0.24b 
  Wine processed 0.51 ± 0.07a 0.19 ± 0.04a 0.66 ± 0.13a 9.39 ± 0.46a 
  Pure compound  0.26 ± 0.01b 0.25 ± 0.072a 0.86 ± 0.20a 8.0 ± 0.25b 
Cerebellum     
  Crude extract 0.25 ± 0.02b 0.21 ± 0.04a 0.96 ± 0.16a 7.50 ± 0.23c 
  Vinegar processed 0.27 ± 0.03b 0.24 ± 0.03a 1.14 ± 0.20a 8.28 ± 0.36bc 
  Wine processed 0.55 ± 0.01a 0.19 ± 0.04a 0.87 ± 0.17a 8.52 ± 0.46ab 
  Pure compound  0.26 ± 0.02b 0.15 ± 0.03a 0.99 ± 0.22a 9.20 ± 0.61a 
Diencephalons     
  Crude extract 0.23 ± 0.01b 0.45 ± 0.10a 1.70 ± 0.29a 7.76 ± 0.23b 
  Vinegar processed 0.25 ± 0.01b 0.51 ± 0.06a 1.88 ± 0.33a 7.31 ± 0.29b 
  Wine processed 0.52 ± 0.03a 0.40 ± 0.09a 1.38 ± 0.27a 9.06 ± 0.57a 
  Pure compound  0.27 ± 0.04b 0.46 ± 0.13a 1.67 ± 0.38a 7.70 ± 0.28b 
Brainstem     
  Crude extract 0.25 ± 0.02b 0.34 ± 0.07a 1.33 ± 0.23a 6.82 ± 0.21b 
  Vinegar processed 0.28 ± 0.01b 0.41 ± 0.04a 1.66 ± 0.30a 7.20 ± 0.25b 
  Wine processed 0.52 ± 0.01a 0.28 ± 0.06a 1.11 ± 0.22a 9.12 ± 0.47a 
  Pure compound  0.25 ± 0.00b 0.37 ± 0.11a 1.49 ± 0.34a 7.53 ± 0.26b 
Hippocampus     
  Crude extract 0.22 ± 0.03a 0.47 ± 0.10a 1.57 ± 0.27a 6.55 ± 0.20a 
  Vinegar processed 0.25 ± 0.01a 0.52 ± 0.05a 1.98 ± 0.35a 6.78 ± 0.29a 
  Wine processed 0.27 ± 0.02a 0.39 ± 0.11a 1.49 ± 0.30a 6.78 ± 0.30a 
  Pure compound  0.24 ± 0.05a 0.47 ± 0.13a 1.79 ± 0.40a 7.04 ± 0.23a 
Striatum     
  Crude extract 0.25 ± 0.02a 0.72 ± 0.15a 2.40 ± 0.42a 6.30 ± 0.18b 
  Vinegar processed 0.22 ± 0.07a 0.79 ± 0.09a 2.77 ± 0.49a 6.33 ± 0.28b 
  Wine processed 0.28 ± 0.01a 0.64 ± 0.18a 2.10 ± 0.42a 5.34 ± 0.17c 
  Pure compound  0.21 ± 0.03a 0.72 ± 0.21a 2.47 ± 0.57a 7.69 ± 0.26a 
Molecules 2012, 17 958 
 
2.1.3. Effect of Vinegar and Wine Processing on the Tissue Distribution of DHC 
The time to reach Cmax for DHC was significantly increased in heart, kidney, cerebrum, brainstem 
and striatum as a result of vinegar processing (Table 3 and Figure 4). Tmax of DHC in vinegar 
processing groups was twice higher in heart and kidney, three times higher in brain stem, four times 
higher in cerebellum and striatum and six times higher in cerebrum than in the unprocessed control. 
Wine processing sped up the distribution of DHC in liver, spleen, diencephalons. However, the time to 
reach the peak concentration was delayed in heart, kidney, cerebrum and striatum after wine 
processing. Both vinegar and wine processing did not significantly change Tmax of DHC in lung.  
Table 3. Pharmacokinetic parameters of DHC in rat tissues. Data are mean ± SD (n = 5). 
Data of four groups in each tissue indexed by different letters are significantly different 
according to one-way ANOVA followed by Tukey’s test (p < 0.05). 
Tissue Tmax (h) Cmax (µg/mL) AUC0–24 h (µg·h/mL) MRT (h) 
Heart     
  Crude extract 0.25 ± 0.01b 0.68 ± 0.14a 1.33 ± 0.23a 4.20 ± 0.07a 
  Vinegar processed 0.51 ± 0.00a 0.54 ± 0.10a 0.97 ± 0.18a 5.05 ± 0.15a 
  Wine processed 0.53 ± 0.01a 0.47 ± 0.10a 0.99 ± 0.20a 6.12 ± 0.36a 
  Pure compound 0.25 ± 0.00b 0.44 ± 0.13a 0.85 ± 0.12a 8.72 ± 6.38a 
Liver     
  Crude extract 1.12 ± 0.02a 1.03 ± 0.21a 2.90 ± 0.51a 4.48 ± 0.12bc 
  Vinegar processed 0.53 ± 0.03b 0.85 ± 0.17a 2.13 ± 0.39ab 6.43 ± 0.20a 
  Wine processed 0.25 ± 0.00c 0.88 ± 0.25a 1.89 ± 0.40ab 4.19 ± 0.13c 
  Pure compound 0.25 ± 0.00c 0.62 ± 0.18a 1.57 ± 0.34b 4.85 ± 0.10b 
Spleen     
  Crude extract 1.01 ± 0.07a 0.53 ± 0.10a 1.13 ± 0.20a 5.06 ± 0.10a 
  Vinegar processed 0.50 ± 0.06b 0.46 ± 0.09a 0.78 ± 0.14a 3.97 ± 0.11b 
  Wine processed 0.58 ± 0.00b 0.40 ± 0.09a 0.83 ± 0.17a 3.50 ± 0.10c 
  Pure compound 0.25 ± 0.10c 0.36 ± 0.08a 0.83 ± 0.19a 3.26 ± 0.08c 
Lung     
  Crude extract 0.50 ± 0.00a 0.58 ± 0.12a 1.32 ± 0.23a 5.44 ± 0.15a 
  Vinegar processed 0.54 ± 0.02a 0.50 ± 0.10a 0.84 ± 0.16ab 4.34 ± 0.11b 
  Wine processed 0.51 ± 0.09a 0.43 ± 0.10a 0.98 ± 0.20ab 4.61 ± 0.15b 
  Pure compound 0.25 ± 0.01b 0.37 ± 0.11a 0.57 ± 0.13b 3.98 ± 0.10c 
Kidney     
  Crude extract 0.25 ± 0.02c 0.51 ± 0.05ab 1.51 ± 0.05a 5.01 ± 0.07a 
  Vinegar processed 0.53 ± 0.01b 0.40 ± 0.03b 1.22 ± 0.08a 5.05 ± 0.03a 
  Wine processed 1.51 ± 0.01a 0.40 ± 0.03b 0.94 ± 0.07a 4.17 ± 0.29b 
  Pure compound 0.25 ± 0.01c 0.31 ± 0.02b 0.89 ± 0.09b 4.94 ± 0.12a 
Cerebrum     
  Crude extract 0.25 ± 0.00b 0.22 ± 0.24a 0.22 ± 0.03a 5.18 ± 0.10b 
  Vinegar processed 1.55 ± 0.03a 0.05 ± 0.01a 0.19 ± 0.03a 4.90 ± 0.10b 
  Wine processed 1.50 ± 0.01a 0.06 ± 0.01a 0.19 ± 0.04a 6.79 ± 0.34a 
  Pure compound 0.25 ± 0.02b 0.05 ± 0.01a 0.15 ± 0.03a 5.39 ± 0.19ab 
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Table 3. Cont. 
Tissue Tmax (h) Cmax (µg/mL) AUC0–24 h (µg·h/mL) MRT (h) 
Cerebellum     
  Crude extract 0.25 ± 0.05c 0.07 ± 0.01a 0.29 ± 0.06a 6.16 ± 0.19a 
  Vinegar processed 1.09 ± 0.03a 0.06 ± 0.011a 0.20 ± 0.03ab 6.25 ± 0.30a 
  Wine processed 0.58 ± 0.08b 0.06 ± 0.01a 0.18 ± 0.04ab 6.82 ± 1.08a 
  Pure compound 0.25 ± 0.00c 0.05 ± 0.02a 0.17 ± 0.03b 5.67 ± 0.32a 
Diencephalons     
  Crude extract 2.12 ± 0.08a 0.07 ± 0.02a 0.35 ± 0.06a 9.22 ± 0.40a 
  Vinegar processed 1.07 ± 0.12b 0.09 ± 0.02a 0.26 ± 0.04ab 8.10 ± 0.29b 
  Wine processed 0.53 ± 0.04c 0.08 ± 0.02a 0.20 ± 0.04b 4.96 ± 0.15c 
  Pure compound 0.52 ± 0.11c 0.08 ± 0.02a 0.21 ± 0.05b 5.30 ± 0.12c 
Brain stem     
  Crude extract 0.51 ± 0.02b 0.22 ± 0.04a 0.60 ± 0.10a 4.21 ± 0.10c 
  Vinegar processed 1.53 ± 0.05a 0.17 ± 0.03a 0.58 ± 0.11a 6.25 ± 0.16a 
  Wine processed 0.54 ± 0.01b 0.17 ± 0.03a 0.50 ± 0.10a 5.46 ± 0.13b 
  Pure compound 0.50 ± 0.00b 0.16 ± 0.03a 0.41 ± 0.06a 4.29 ± 0.15c 
Hippocampus     
  Crude extract 1.51 ± 0.23b 0.09 ± 0.01a 0.37 ± 0.06a 8.15 ± 0.21a 
  Vinegar processed 1.54 ± 0.06b 0.07 ± 0.01a 0.28 ± 0.05a 8.68 ± 0.76a 
  Wine processed 2.07 ± 0.21a 0.07 ± 0.02a 0.28 ± 0.05a 9.35 ± 0.88a 
  Pure compound 1.08 ± 0.07c 0.07 ± 0.02a 0.27 ± 0.06a 8.43 ± 0.51a 
Striatum     
  Crude extract 0.25 ± 0.00c 0.09 ± 0.02a 0.20 ± 0.07a 7.15 ± 0.22a 
  Vinegar processed 1.01 ± 0.03a 0.06 ± 0.02a 0.24 ± 0.04a 6.70 ± 0.43a 
  Wine processed 0.52 ± 0.04b 0.06 ± 0.01a 0.22 ± 0.04a 5.19 ± 0.11b 
  Pure compound 0.25 ± 0.01c 0.06 ± 0.02a 0.21 ± 0.04a 7.27 ± 0.30a 
Figure 4. Time dependent changes of DHC in rat tissues. (a) Heart, liver, spleen, lung and 
kidney; (b) Six parts of brain including cerebrum, cerebellum, diencephalons, brainstem, 
hippocampus, striatum. Data are mean ± SD (n = 5). 
(a) 
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Figure 4. Cont. 
 
 
(b) 
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Figure 4. Cont. 
 
Peak concentration of DHC in liver was the highest, followed by heart, lung, spleen, kidney and 
brain, respectively. In six parts of brain, Cmax of DHC in brain stem and cerebrum was higher than 
other parts. No significant changes were observed on Cmax and AUC0–24 h of DHC in all tissue 
examined after processing (p > 0.05). MRT of DHC ranged from 4.2 h (in heart) to 9.22 h 
(diencephalons) after administration of unprocessed Rhizoma Corydalis. Vinegar processing 
significantly prolonged the MRT of DHC in liver and brain stem while MRT of DHC in spleen, lung, 
cerebrum and diencephalons was shortened. The effect of wine processing on MRT of DHC in liver, 
kidney, cerebrum and striatum was different from the vinegar processing. In kidney and striatum, MRT 
of DHC was significantly decreased by wine processing of Rhizoma Corydalis, while no significant 
differences were observed in vinegar processing group. Wine processing significantly prolonged the 
MRT of DHC in cerebrum compared with crude extract group and vinegar processing group. 
2.1.4. Effect of Vinegar and Wine Processing on the Tissue Distribution of Protopine 
Protopine reached the Cmax at about 5 h in heart, liver, spleen, lung and kidney after administration 
of unprocessed Rhizoma Corydalis (Table 4 and Figure 5a). In six sections of brain, Tmax of protopine 
was 2 h after administration of unprocessed Rhizoma Corydalis. Vinegar processing prolonged the 
Tmax of protopine to 3 h in all six parts of brain (Figure 5b). In contrast, there was no significant 
change on Tmax of protopine in heart, liver, spleen, lung and kidney after vinegar processing. Two 
hours decrease in the Tmax of protopine were observed in wine processing group compared with 
unprocessed in the tissues of heart, liver, spleen, lung and kidney. However, wine processing did not 
change the Tmax of propopine in brain.  
The highest Cmax of protopine among the tissues examined after administration of unprocessed of 
Rhizoma Corydalis was 11.42 ± 1.42 µg/mL in lung followed by spleen, liver, kidney, striatum, 
hippocampus, cerebellum, heart, cerebrum, diencephalons and brain stem. There were no significant 
differences on the value of Cmax and AUC0–24 h of protopine after vinegar and wine processing. MRT of 
protopine was notably delayed by vinegar processing in lung, cerebrum, diencephalons, brain stem and 
hippocampus, while, it was significantly reduced in heart, spleen and kidney. Wine processing 
significantly shortened the MRT of protopine in heart, spleen, lung, kidney, cerebellum, hippocampus 
and diencephalons.  
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Table 4. Pharmacokinetic parameters of protopine in rat tissues. Data are mean ± SD  
(n = 5). Data of four groups in each tissue indexed by different letters are significantly 
different according to one-way ANOVA followed by Tukey’s test (p < 0.05). 
Tissue Tmax (h) Cmax (µg/mL) AUC0–24 h (µg·h/mL) MRT (h) 
Heart     
  Crude extract 5.11 ± 0.24a 1.51 ± 0.18a 6.26 ± 0.92a 5.93 ± 0.02a 
  Vinegar processed 5.07 ± 0.15a 1.59 ± 0.43a 5.61 ± 1.06a 5.70 ± 0.03b 
  Wine processed 3.55 ± 0.31b 1.49 ± 0.30a 4.22 ± 0.85a 4.85 ± 0.03c 
  Pure compound  5.28 ± 0.42a 1.50 ± 0.45a 6.23 ± 1.56a 5.93 ± 0.02a 
Liver     
  Crude extract 5.32 ± 0.12a 6.78 ± 0.78a 29.16 ± 4.24a 5.46 ± 0.01b 
  Vinegar processed 5.25 ± 0.16a 6.91 ± 1.42a 28.13 ± 5.30a 5.28 ± 0.02b 
  Wine processed 3.07 ± 0.10b 6.91 ± 1.40a 19.30 ± 3.84a 5.46 ± 0.17ab 
  Pure compound  5.09 ± 0.68a 6.67 ± 1.97a 27.83 ± 6.98a 5.69 ± 0.03a 
Spleen     
  Crude extract 5.87 ± 0.32a 7.55 ± 0.87a 34.91 ± 5.19a 5.59 ± 0.03a 
  Vinegar processed 5.12 ± 0.34a 7.05 ± 1.45a 33.36 ± 6.42a 5.29 ± 0.04b 
  Wine processed 3.07 ± 0.61b 7.03 ± 1.41a 20.45 ± 4.13a 3.86 ± 0.03b 
  Pure compound  5.22 ± 0.05a 7.42 ± 2.22a 35.03 ± 8.18a 5.65 ± 0.03a 
Lung     
  Crude extract 5.14 ± 0.26a 11.42 ± 1.42a 51.16 ± 7.69a 5.86 ± 0.03b 
  Vinegar processed 5.63 ± 0.02a 11.78 ± 2.41a 50.69 ± 9.57a 5.97 ± 0.01a 
  Wine processed 3.87 ± 0.05b 10.38 ± 2.08a 31.54 ± 7.27a 4.76 ± 0.03c 
  Pure compound  5.22 ± 0.47a 11.22 ± 3.31a 50.24 ± 12.46a 5.85 ± 0.04b 
Kidney     
  Crude extract 5.01 ± 0.06a 4.49 ± 0.52a 18.65 ± 2.79a 5.54 ± 0.04a 
  Vinegar processed 5.09 ± 0.38a 4.37 ± 0.90a 18.48 ± 3.49a 5.32 ± 0.04b 
  Wine processed 3.10 ± 0.28b 4.60 ± 0.91a 13.78 ± 2.72a 4.93 ± 0.03c 
  Pure compound  5.13 ± 0.04a 4.42 ± 1.31a 13.44 ± 2.65a 5.53 ± 0.04a 
Cerebrum     
  Crude extract 2.09 ± 0.02b 1.46 ± 0.29a 3.87 ± 0.69a 4.22 ± 0.22b 
  Vinegar processed 3.11 ± 0.22a 1.15 ± 0.25a 5.02 ± 0.97a 6.37 ± 0.03a 
  Wine processed 2.08 ± 0.02b 1.50 ± 0.30a 4.57 ± 0.91a 6.21 ± 0.03a 
  Pure compound  2.10 ± 0.80b 1.35 ± 0.27a 3.65 ± 0.78a 3.93 ± 0.06b 
Cerebellum     
  Crude extract 2.13 ± 0.05b 1.69 ± 0.34a 4.41 ± 0.72a 5.56 ± 0.15a 
  Vinegar processed 3.28 ± 0.17a 1.47 ± 0.29a 4.93 ± 0.93a 4.94 ± 0.01b 
  Wine processed 2.21 ± 0.38b 1.65 ± 0.33a 4.67 ± 0.94a 4.98 ± 0.02b 
  Pure compound  2.08 ± 0.01b 1.56 ± 0.32a 3.80 ± 0.83a 4.86 ± 0.08b 
Diencephalons     
  Crude extract 2.11 ± 0.22b 1.37 ± 0.28a 3.48 ± 0.59a 4.94 ± 0.14c 
  Vinegar processed 3.08 ± 0.15a 1.14 ± 0.23a 3.98 ± 0.76a 5.76 ± 0.03a 
  Wine processed 2.03 ± 0.02b 1.43 ± 0.28a 3.91 ± 0.79a 5.42 ± 0.03b 
  Pure compound  2.07 ± 0.21b 1.31 ± 0.27a 3.18 ± 0.07a 4.89 ± 0.01c 
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Table 4. Cont. 
Tissue Tmax (h) Cmax (µg/mL) AUC0–24 h (µg·h/mL) MRT (h) 
Brain stem     
  Crude extract 2.00 ± 0.08b 0.91 ± 0.19a 2.42 ± 0.46a 4.50 ± 0.18b 
  Vinegar processed 3.13 ± 0.41a 0.89 ± 0.18a 2.58 ± 0.46a 4.90 ± 0.19a 
  Wine processed 2.09 ± 0.10b 1.27 ± 0.21a 2.80 ± 0.57a 5.13 ± 0.03a 
  Pure compound  2.20 ± 0.01b 0.82 ± 0.17a 2.02 ± 0.42a 3.90 ± 0.14b 
Hippocampus     
  Crude extract 2.10 ± 0.03b 1.77 ± 0.36a 4.24 ± 0.87a 5.02 ± 0.15b 
  Vinegar processed 3.19 ± 0.18a 1.58 ± 0.31a 5.31 ± 0.97a 6.07 ± 0.16a 
  Wine processed 2.28 ± 0.01b 1.75 ± 0.35a 4.80 ± 0.96a 4.37 ± 0.03c 
  Pure compound  2.09 ± 0.04b 1.56 ± 0.31a 3.66 ± 0.81a 5.23 ± 0.10b 
Striatum     
  Crude extract 2.01 ± 0.01b 2.18 ± 0.44a 6.51 ± 1.44a 6.90 ± 0.20a 
  Vinegar processed 3.02 ± 0.07a 1.85 ± 0.37a 7.23 ± 1.29a 5.51 ± 0.26b 
  Wine processed 2.31 ± 0.02b 2.17 ± 0.44a 7.64 ± 1.50a 6.52 ± 0.01a 
  Pure compound  2.07 ± 0.08b 1.95 ± 0.40a 6.42 ± 1.52a 6.57 ± 0.43a 
Figure 5. Time dependent changes of protopine in rat tissues. (a) Heart, liver, spleen, lung 
and kidney; (b) Six parts of brain including cerebrum, cerebellum, diencephalons, 
brainstem, hippocampus, striatum. Data are mean ± SD (n = 5). 
(a) 
 
 
Molecules 2012, 17 964 
 
Figure 5. Cont. 
 
(b) 
 
 
 
Molecules 2012, 17 965 
 
2.2. Discussion 
The dried rhizome of corydalis, also called Yanhusuo, is a widely used traditional Chinese 
medicine. THP, DHC and protopine are three major bioactive components of the rhizome extract. 
Recently, Chen and the co-authors developed a HPLC-DAD method for simultaneous quantification of 
eight protoberberine quaternary alkaloids from ethanol extract of Rhizoma corydalis [19]. A  
HPLC-ESI/MS method was reported for simultaneous determination of THP, protopine and palmatine 
in rat plasma in 2009 [20]. However, there are still no reports on simultaneous measurement of the 
three main bioactive compounds, namely THP, DHC and protopine, in animal tissues after administration 
of rhizome extract. In this study, we developed and validated a simple, accurate and sensitive method 
for the simultaneous determination of THP, DHC and protopine in rat tissues by HPLC-UV. 
Processing is a crucial step before the Chinese medicinal herbs can be used in prescriptions. Two 
processed products of Rhizoma corydalis (vinegar and wine) have been clinically used in China for 
thousands of years based on the Traditional Chinese Medicine (TCM) Theory [21]. THP is the major 
bioactive compound with analgesic effect [4]. It only took 15 min for THP to reach the Cmax in all the 
tissues examined after administration of unprocessed Rhizoma corydalis (Figure 3). This indicated that 
Rhizoma corydalis is a fast pain relief drug. Vinegar processed Rhizoma corydalis is recommended  
in TCM prescriptions when they are used for the treatment of the pain in stomach, chest and  
dysmenorrhe [22]. Previous report showed that the analgesic effect of Rhizoma corydalis was more 
intense when vinegar processed products were used compared with unprocessed Rhizoma corydalis [17]. 
However, in this study, we observed that vinegar processing does not significantly change the tissue 
distribution of THP. The improvement of analgesic effect by using vinegar processed Rhizoma corydalis 
might be because of the increase of THP when the same amount of plant materials was used [18]. The 
slower absorption of THP was observed after wine processing in heart, liver, spleen, lung and 
cerebrum. Therefore, wine processed products should not be used for the treatment of acute pain in 
these organs. In addition, several THP poisoning cases were reported after administration of THP pure 
compound [23]. In our study, the concentration of THP in the tissues dropped quickly after it arrived at 
the peak concentration and after 12 h, the concentration of THP in the tissues was only 1/17~1/49 of 
the Cmax. This indicated that administration of Rhizoma corydalis instead of THP pure compound will 
not cause the accumulation of THP in the tissue. 
DHC is the bioactive compound in Rhizoma corydalis for the treatment of coronary heart disease 
through the protective effect on cardiomyocytes and the inhibition of myocardial apoptosis [9,10,24]. 
Our results supported this conclusion because the Cmax of DHC was higher in heart than that in other 
tissues except liver after administration of unprocessed Corydalis (Table 3). Wine processed  
Rhizoma corydalis is widely used in TCM practices for coronary heart diseases [25]. However, in our 
study, both vinegar and wine processing deferred the time for DHC to reach the peak concentration in 
heart. In addition, there were no significant changes on Cmax and AUC0–24 h. These results indicated that 
processing is not necessary when Rhizoma corydalis is used for the treatment of coronary heart disease. 
It is well known that protopine has vasodilator effects which are related to the elevations of cAMP 
and cGMP and calcium antagonism [26]. Our data showed that Cmax of protopine in lung is higher than 
in other tissues after administration of unprocessed Rhizoma corydalis (Table 4). This indicated that 
Rhizoma corydalis has better vasodilator effect on the smooth muscle in lung and can be used for the 
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treatment of asthma. Wine processing accelerated the distribution of protopine in lung by reducing the 
Tmax, in contrast, processing of Rhizoma corydalis with vinegar significantly increased the MRT of 
protopine in lung without changing other pharmacokinetic parameters. Therefore, wine processing is 
recommended when Rhizoma corydalis is used for cough relief. In addition, recent studies showed  
that protopine is able to relieve H2O2-induced oxidative stress and apoptosis caused by cerebral  
ischaemic [11,27]. In this study, we found that the speed of the tissue distribution of protopine was 
much slower than the unprocessed group in all six sections of the brain (Table 4). A possible reason is 
that the acetic acid in vinegar forms a complex with protopine and the diffusion of the protopine-acetic 
acid salt to the brain tissues might be restricted by the blood brain barrier [28]. Based on our results, 
we suggested that either unprocessed or processed with wine should be used for cerebral ischaemia.  
3. Experimental  
3.1. Chemicals 
THP, protopine and nuciferine pure compound were obtained from the National Institute for the 
Control of Pharmaceutical and Biological Products (Beijing, China). DHC was obtained from Wako 
Pure Chemical Industries, LTD. (Japan). Unprocessed Rhizoma Corydalis was purchased from Tianjin 
ZhongXin Pharmaceutical Group Corporation Limited (Tianjin, China). HPLC-grade methanol and 
acetonitrile were purchased from Tianjin Union Hope Chromatography Technological Corporation 
Limited (Tianjin, China). Yellow wine and edible vinegar used for processing were purchased from 
Tianjin Tianliduliu Mature Vinegar Co. LTD. The content of ethanol in the wine is 15%–20% (v/v). 
The vinegar is derived from rice and the acetic acid content in the vinegar is 4%–6% (v/v). 
3.2. Animals 
The experimental protocol was approved by the University’s Animal Ethics Committee. Healthy 
Wistar male rats (body weight 250 g ± 20 g, mean ± SD) were purchased from Institute of Laboratory 
Animal Sciences, Chinese Academy of Medical Sciences (Beijing, China) and maintained in a 
temperature and humidity controlled facility. Rats had unlimited access to water. Standard food was 
given until 12 h before the experiments. 
3.3. Preparation of Rhizoma Corydalis Extract 
Rhizoma Corydalis was processed according to Pharmacopoeia of Chinese Medicine and National 
Guideline of Traditional Chinese Medicinal Plants Processing [12]. Briefly, fresh Rhizoma Corydalis 
was boiled in water till the pith turn light brown color. Cooked rhizome was sliced into pieces (4 mm, 
diameter) and dried at 25 °C. Dried slices were mixed with edible vinegar (100:20, rhizome/vinegar, 
w/v) or yellow wine (100:10, rhizome/wine, w/v) and the slices allowed to completely absorb the 
vinegar or wine. The soaked slices were then stir-fried in a metallic pan over a low flame till they were 
completely dry. The processed Rhizoma Corydalis was added with 70% ethanol (1:30 w/v) and 
sonicated for 1 h at room temperature. The extract was then concentrated to remove the ethanol residue 
and stored at 4 °C for further use. The major components in the ethanol extract are three alkaloids 
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including THP, DHC and protopine [15]. The ethanol extract of the unprocessed Rhizoma Corydalis 
and THP, DHC and protopine pure compound were used as the controls. 
3.4. Administration and Tissue Sample Collection 
Three hundred and sixty healthy rats were used in total and are divided into six groups (Group 1–6, 
sixty rats per group). Drugs were administrated by gastric gavage method. In order to keep the dose of 
THP, DHC and protopine constant in each group, the amount of ethanol extract of Rhizoma Corydalis 
administrated was normalized based on the dose of protopine pure compound used. The dose of THP 
and DHC pure compound administrated was same with that in the ethanol extract of Rhizoma 
Corydalis. The details were listed below. Group 1: Rats were administrated with the 70% ethanol 
extract of unprocessed Rhizoma Corydalis at a dose of 17.75 g extract/kg body weight. Group 2: Rats 
received the extract of vinegar-processed Rhizoma Corydalis at a dose of 15 g extract/kg rat body 
weight. Group 3: Rats were administrated with the extract of wine processed Rhizoma Corydalis at a 
dose of 15.78 g extract/kg body weight. Group 4: Rats were administrated 4.52 mg/kg body weight of 
protopine pure compound. Group 5: Rats received THP pure compound at a dose of 6.45 mg/kg body 
weight. Group 6: Rats were administrated 26.10 mg of DHC pure compound/kg body weight. Blood 
and tissues (heart, liver, spleen, lung, kidney, brain) were collected at 0.083, 0.25, 0.5, 1, 1.5, 2, 3, 5, 8, 
12 h (5 rats/per group/per time) after administration. Brian tissue was further dissected into six parts: 
cerebrum, cerebellum, diencephalons, brain stem, hippocampus and striatum. All the tissue samples 
were rinsed with ice-old saline and stored at −20 °C until extraction. 
3.5. Extraction Procedures 
Tissue samples were homogenized in three volumes of ice-cold biological saline and centrifuged for  
10 min at 10,000 g and 4 °C. An aliquot of the supernatant (0.5 mL) was collected. Liquid-liquid 
extraction was used to extract THP, DHC and protopine. One hundred microliter of 1.0 µg/mL 
nuciferin (internal standard) was mixed with 0.5 mL aliquots of the supernatant. The mixture was 
extracted with 1.49 mL of methanol by vortexing for 2 min and centrifuged at 10,000 g for 10 min. 
The supernatant was evaporated completely under the nitrogen stream in a 60 °C water bath. The 
residue was redissolved in 100 µL of methanol. 
3.6. Simultaneous Determination of THP, DHC and Protopine in Rat Tissues 
A CoMetro HPLC system (CoMetro Technology Ltd, South Plainfiled, NJ, USA) with 6000 PVW 
detector UV-VIS detector was used. Separation was achieved by injecting 50 µL sample into a 
Kromasil ODS-C18 (250 mm × 4.6 mm, 5 µm) (packed by Dalian Elite Analytical Instruments Co. 
Ltd., Liaoning, China). Other chromatographic conditions were: column temperature, 35 °C; mobile 
phase, acetonitrile-0.1% phosphoric acid (pH 3.0) (30:70 v/v); flow rate, 1 mL/min; wavelength, 280 nm. 
3.7. Validation of the Method for Quantitative Analysis of THP, DHC and Protopine in Rat Tissues 
Method validation was examined for assay specificity, precision, linearity, accuracy, and extraction 
recovery under the HPLC analytical conditions described above. Stock solution of THP, protopine, and 
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DHC was prepared in methanol at concentration of 150 µg/mL and mixed. Working solution of the 
analytes was prepared by serial dilution of the stock. The specificity of the method was assessed by 
preparing and analyzing six different batches of drug-free rat tissues. The chromatograms of blank 
tissue samples were compared with those obtained with the analytes (THP (0.306 µg/mL), DHC  
(0.294 µg/mL), protopine (0.320 µg/mL) and nuciferine (1.0 µg/mL)) and those after administration of 
Rhizoma Corydalis extracts. The standard curve was constructed using a linear least-square regression 
equation derived from the peak area. Accuracy was evaluated as the relative error (R.E.), and precision 
was determined as the relative standard deviation (R.S.D.). The accuracy and the precision of the 
assays for intra-day and inter-day determinations were evaluated by the analysis of three concentrations 
(six replicates for each) on the same day and on three consecutive validation days, respectively. The 
relative extraction recovery was calculated by comparing the peak area of tissue-extracted standards 
with that obtained from the extracted blank tissue sample post spiked with the corresponding standards 
(n = 5). The absolute recovery was calculated by comparing the peak area of extracted samples with 
that of the standard solution containing an equivalent amount of the analytes (n = 5). 
3.8. Pharmacokinetic and Statistical Analysis 
Pharmacokinetic parameters were estimated by non-compartmental analysis using Equiv Test/PK 
(Statistical Solutions Ltd., Saugus, MA, USA). The maximum concentration (Cmax) and the time to 
reach the maximum concentration (Tmax) were directly obtained from the observed value. All data were 
represented as mean ± SD. Comparison of values between groups was performed using one-way 
ANOVA followed by Tukey’s test for comparisons among four groups. A value of p < 0.05 was 
considered significantly difference. 
4. Conclusions 
In this paper, a sensitive, simple and accurate HPLC method has been developed and validated for 
the simultaneous quantification of the three main bioactive compounds (THP, DHC and protopine) in 
rat tissues after administration of ethanol extract of Rhizoma corydalis. The validated method has been 
successfully used to investigate the effect of vinegar and wine processing on the distribution of THP, 
DHC and protopine in the rat tissues. Our results showed that vinegar and wine processing mainly 
affect the Tmax and MRT and the effect varies in different tissues and among different bioactive 
compounds. Our results suggested that differently processed Rhizoma corydalis products (unprocessed, 
wine processed or vinegar processed) should be selected according to the specific disease condition 
and the affected organs. 
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